Literature DB >> 10946298

The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection.

J B Domachowske1, C A Bonville, J L Gao, P M Murphy, A J Easton, H F Rosenberg.   

Abstract

In this work, we explore the responses of specific gene-deleted mice to infection with the paramyxovirus pneumonia virus of mice (PVM). We have shown previously that infection of wild type mice with PVM results in pulmonary neutrophilia and eosinophilia accompanied by local production of macrophage-inflammatory protein-1 alpha (MIP-1 alpha). Here we examine the role of MIP-1 alpha in the pathogenesis of this disease using mice deficient in MIP-1 alpha or its receptor, CCR1. The inflammatory response to PVM in MIP-1 alpha-deficient mice was minimal, with approximately 10-60 neutrophils/ml and no eosinophils detected in bronchoalveolar lavage fluid. Higher levels of infectious virus were recovered from lung tissue excised from MIP-1 alpha-deficient than from fully competent mice, suggesting that the inflammatory response limits the rate of virus replication in vivo. PVM infection of CCR1-deficient mice was also associated with attenuated inflammation, with enhanced recovery of infectious virus, and with accelerated mortality. These results suggest that the MIP-1 alpha/CCR1-mediated acute inflammatory response protects mice by delaying the lethal sequelae of infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946298     DOI: 10.4049/jimmunol.165.5.2677

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 2.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

3.  The role of MIP-1alpha in experimental hypersensitivity pneumonitis.

Authors:  M Schuyler; K Gott; V French
Journal:  Lung       Date:  2004       Impact factor: 2.584

4.  Chemokine complexity: the case for CCL5.

Authors:  Mitchell H Grayson; Michael J Holtzman
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08       Impact factor: 6.914

5.  Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors:  Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 6.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Granzyme A- and B-cluster deficiency delays acute lung injury in pneumovirus-infected mice.

Authors:  Reinout A Bem; Job B M van Woensel; Rene Lutter; Joseph B Domachowske; Jan Paul Medema; Helene F Rosenberg; Albert P Bos
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

8.  Role of T cells in virus control and disease after infection with pneumonia virus of mice.

Authors:  Stefanie Frey; Christine D Krempl; Annette Schmitt-Gräff; Stephan Ehl
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  Mechanical ventilation enhances lung inflammation and caspase activity in a model of mouse pneumovirus infection.

Authors:  Reinout A Bem; Job B M van Woensel; Albert P Bos; Amy Koski; Alex W Farnand; Joseph B Domachowske; Helene F Rosenberg; Thomas R Martin; Gustavo Matute-Bello
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-07       Impact factor: 5.464

10.  Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo.

Authors:  Cynthia A Bonville; Vincent K Lau; Jordana M DeLeon; Ji-Liang Gao; Andrew J Easton; Helene F Rosenberg; Joseph B Domachowske
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.